Literature DB >> 10098795

Acute hepatitis B infection in England and Wales: 1985-96.

M A Balogun1, M E Ramsay, C K Fairley, M Collins, J Heptonstall.   

Abstract

Confirmed acute hepatitis B infections are reported to the Public Health Laboratory Service Communicable Disease Surveillance Centre by laboratories in England and Wales. These reports have been used to monitor trends in the incidence of hepatitis B virus (HBV) infection over time, and between exposure categories and age groups. Between 1985 and 1996 a total of 9252 cases of acute HBV infection were reported; the number of reports fell from 1761 in 1985 to 581 in 1996. Most infections were reported in adults aged 15-44 years [n = 7365 (80%)], and infections were more commonly reported in males [n = 6490 (70%)] than females [n = 2658 (29%)]. The probable means of acquisition was known for just over half of all adult cases [4827/8956 (54%)]. Injecting drug use was the most common exposure [n = 1901 (21%)], followed by sex between men and women [n = 1140 (13%)] and sex between men [n = 1025 (11%)]. The number of infections in injecting drug users fell in the late 1980s, but increased again from 1991 onwards. In children aged under 15 years, infections acquired by mother to baby transmission accounted for 35/170 (21%) of the total. Surveillance indicates that the incidence of acute hepatitis B infection fell in the late 1980s, probably reflecting changed behaviour in injecting drug users. An increase in the number of infections in injecting drug users since 1993 may indicate ongoing transmission that has not been contained by the introduction of needle exchange schemes or by selective vaccination.

Entities:  

Mesh:

Year:  1999        PMID: 10098795      PMCID: PMC2809597          DOI: 10.1017/s0950268898001733

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 2.  Behavioural surveillance: the value of national coordination.

Authors:  C A McGarrigle; K A Fenton; O N Gill; G Hughes; D Morgan; B Evans
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

3.  Hepatitis A, B, and C.

Authors:  R Gilson; M G Brook
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

4.  Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003.

Authors:  Z Hong; G Smart; G Zaniewski; H Wu; J Wu; N Goedhuis; A Giulivi; K Kaita; M Dawood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

5.  A cross-sectional analysis of acute hepatitis B virus reported to the Vancouver Coastal Health Authority from 2000 to 2003.

Authors:  Yvette Leung; Jessica Ip Chan; Eric Yoshida; Hong-Xing Wu; Patricia C Daly
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Enhanced surveillance of acute hepatitis B and C in four health regions in Canada, 1998 to 1999.

Authors:  S Zou; J Zhang; M Tepper; A Giulivi; B Baptiste; G Predy; D Poliquin; M Morin; D Jones; J Lowewen; M Ogonowski; S Moses; L Elliott
Journal:  Can J Infect Dis       Date:  2001-11

8.  Sero-prevalence of hepatitis B virus infection in Balochistan Province of Pakistan.

Authors:  Nadeem S Sheikh; Azeem S Sheikh; Aqleem A Sheikh; Samira Yahya; Majid Lateef
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

9.  Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England.

Authors:  M A Balogun; J V Parry; K Mutton; C Okolo; L Benons; H Baxendale; T Hardiman; E H Boxall; J Sira; M Brown; S Barnett; U Gungabissoon; A Williams; D A Kelly; S Vijeratnam; S Ijaz; B Taylor; C G Teo; M E Ramsay
Journal:  Epidemiol Infect       Date:  2012-07-31       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.